Skip to main content
Equibles

Erste Asset Management GmbH

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 2024532 VIENNA, C4
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$3,382,610
+$406,448 QoQ
Shares Held
133,700
0.0% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#93
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Erste Asset Management GmbH holds $553,204,959 across 68 Biotechnology names. ACAD ranks #27 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AGIO
Agios Pharmaceuticals, Inc.
 2,154,900 $79,968,339
2 MDGL
Madrigal Pharmaceuticals, Inc.
 110,210 $59,177,259
3 SRPT
Sarepta Therapeutics, Inc.
 2,568,945 $46,163,941
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 76,558 $38,028,654
5 ROIV
Roivant Sciences Ltd.
 834,000 $29,515,260
6 DNA
Ginkgo Bioworks Holdings, Inc.
 2,536,939 $25,141,065
7 REGN
Regeneron Pharmaceuticals, Inc.
 38,716 $24,140,974
8 MIRM
Mirum Pharmaceuticals, Inc.
 205,000 $23,999,350

All Filings in ACAD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,382,610 133,700
2026-03-31 $2,976,162 133,700
2025-12-31 $3,571,127 133,700
2025-09-30 $2,853,158 133,700
2025-06-30 $3,889,071 180,300
2025-03-31 $4,024,603 242,300
2024-12-31 $4,446,205 242,300
2024-09-30 $3,726,574 242,300
2024-06-30 $3,937,375 242,300
2024-03-31 $4,480,127 242,300
2023-12-31 $4,643,273 148,300
2023-09-30 $2,763,384 132,600
2023-06-30 $2,169,870 90,600
2023-03-31 $1,705,092 90,600
2022-12-31 $1,442,352 90,600
2022-09-30 $1,482,216 90,600
2022-06-30 $1,276,554 90,600
2022-03-31 $2,194,332 90,600
2021-12-31 $2,369,010 101,500
2021-09-30 $1,685,915 101,500
2021-06-30 $2,475,585 101,500
2021-03-31 $2,618,700 101,500
2020-12-31 $5,426,190 101,500
2020-09-30 $5,053,125 122,500
2020-06-30 $5,040,880 104,000
2020-03-31 $4,858,750 115,000